21 studies found for:    Tysabri | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Tysabri
2 Recruiting TOP: IMA-06-02 Tysabri Observational Program
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Natalizumab
3 Recruiting PK and PD Study of Natalizumab in Pediatric Subjects With RRMS
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Biological: Natalizumab
4 Recruiting The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Tysabri ® (Natalizumab)
5 Recruiting CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Condition: Crohn's Disease
Intervention: Drug: Natalizumab
6 Recruiting Ireland TYSABRI® (Natalizumab) Observational Program (iTOP)
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Relapsing Remitting Multiple Sclerosis
Intervention:
7 Recruiting Pregnancy Exposure Registry for Tysabri
Conditions: Multiple Sclerosis;   Prenatal Exposure;   Pregnancy
Intervention:
8 Unknown  BG00002 Study in Japanese Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis
Interventions: Biological: BG00002;   Biological: Placebo
9 Not yet recruiting Alternative Treatment Paradigm for Natalizumab Trial
Condition: Multiple Sclerosis (MS)
Intervention: Drug: methylprednisolone
10 Recruiting Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention:
11 Not yet recruiting Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab
Conditions: Multiple Sclerosis;   Cognitive Impairment
Intervention:
12 Recruiting Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
13 Recruiting Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients
Condition: Relapsing-remitting Multiple Sclerosis
Intervention:
14 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
15 Recruiting Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Other: mitoxantrone - immunomodulator;   Other: natalizumab
16 Recruiting Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design
Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
17 Recruiting Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Biological: BG00002;   Drug: Placebo
18 Recruiting Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Condition: Progressive Multifocal Leukoencephalopathy
Intervention:
19 Unknown  A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Other: MSDX Complex-1 Biomarker test
20 Recruiting Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study
Condition: Multiple Sclerosis
Interventions: Procedure: Hematopoietic Stem Cell Therapy;   Drug: Standard treatment with a conventional drug

Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results
Indicates status has not been verified in more than two years